Abstract
This paper gives a ginancial analysis of Pfizer Inc. It includes ratio analysis (liquidity, efficiency and profitability), asset management, debt management, and assessment of market return. The paper concludes with a discussion of the price/earnings ratio for Pfizer stock.

From the Paper
"The results of a financial analysis on Pfizer Inc. a publicly traded company are presented in this paper. Included in the analyses are a ratio analysis, liquidity efficiency and profitability assessment of asset management, assessment of debt management and assessment of market returns. Ratio Analysis Liquidity: Efficiency and Profitability The results of ratio analyses are presented in this section. Ratios are considered in relation to liquidity, efficiency and profitability. Liquidity: Liquidity is assessed in relation to four..."

Tags:ratio analyses, debt, asset management, Pfizer

Abstract
The paper discusses how Pfizer has been quite effective at utilizing marketing strategy based market development to expand its revenue streams and extend the useful life of its existing products. The paper highlights how Pfizer understands that success at marketing its leading products has been one of the company's primary strengths over the last 4-5 years.

From the Paper
"Pfizer has been quite effective at utilizing marketing strategy based market development to expand its revenue streams and extend the useful life of its existing products. Pfizer understands that success at marketing its leading products has been one of the company's primary strengths over the last 4-5 years. Pfizer's sales and marketing division is one of the industries best and has been a strong contributor to creating one of the most pathological advertising establishments in the United States: "The success of psychotropic advertising in assuring people...""

Tags:pfizer, organizational, ansoff

Abstract
This paper discusses the marketing strategy of a major pharmaceutical industry competitor, Pfizer. The competitive environment of the pharmaceutical industry is examined within the context of Porter's five forces model and Merck is utilized as an illustrative competitor.

From the Paper
"The following proposal discusses the marketing strategy of a major pharmaceutical industry competitor: Pfizer. The competitive environment of the pharmaceutical industry is examined within the context of Porter's five forces model and Merck is utilized as an illustrative competitor. The problem statement questions whether Pfizer's marketing strategy is adequate for the present global environment and what possible strategic adjustments it could take to better position itself in the market. The theoretical research approach of the study is qualitative with a reliance..."

Tags:pfizer, marketing, event

Abstract
The paper examines the competitive environment of the pharmaceutical industry within the context of Porter's five forces model and utilizes Merck as an illustrative competitor. The paper's problem statement questions whether Pfizer's marketing strategy is adequate for the present global environment and what possible strategic adjustments it could take to better position itself in the market.

From the Paper
"This marketing audit discusses the marketing strategy of a major pharmaceutical industry competitor: Pfizer. The competitive environment of the pharmaceutical industry is examined within the context of Porter's five forces model and Merck is utilized as an illustrative competitor. The problem statement questions whether Pfizer's marketing strategy is adequate for the present global environment and what possible strategic adjustments it could take to better position itself in the market. The theoretical research approach of the study is qualitative with a reliance on grounded theory which argues that the research itself should not only..."

Tags:pfizer, marketing, audit

Abstract
This paper presents an analysis of Pfizer, the largest American pharmaceutical company, the company's strategic priorities and an analysis of an acquisition. The paper includes a SWOT analysis of the company's strengths and weaknesses and the opportunities and threats it faces.

From the Paper
"Pfizer is the largest American pharmaceutical company and one of the largest pharmaceutical companies in the world. It competes with Merck and Glaxo and markets such well-known medications as Celebrex and Viagra ..."

Tags:Pfizer, pharmaceutical analysis, SWOT

Abstract
The paper discusses the pharmaceutical giant, Pfizer, as a marketing powerhouse. This report overviews some of its key products and tactics it uses in marketing them to consumers, physicians and managed care organizations.

From the Paper
"Marketing powerhouse Pfizer began back in - as a chemicals company. Today it is a billion global enterprise and is one of the top pharmaceutical companies in the world. Pfizer's core products include Aricept Alzheimer's disease, Celebrex pain, Diflucan infection, Lipitor high cholesterol, Neurontin pain and epilepsy, Norvasc high blood pressure, Viagra erectile dysfunction, Xalatan glaucoma, Zithromax infection, Zoloft depression and Zyrtec allergy. The ultimate goal of Pfizer's marketing strategy is to increase drug sales which for prescription pharmaceuticals can only be accomplished by increased prescription writing."

Tags:Pfizer, pharmaceutical marketing, direct to consumer advertising, physician detailing, managed care organizations

Abstract
This paper explains the history, management and organization of Pfizer Pharmaceuticals and its industry. The author reports that accounting ratios are the key basis for the financial analysis of this company based on data from 2005, 2006 and 2007. Computations are included in the paper. The paper indicates that the drop in profitability and the declining liquidity, which is probably stemming from cash problems, may hinder potential investors from investing in this organization.

Table of Contents:
Introduction: History on Pfizer Pharmaceuticals
Management Level of the Pfizer Incorporation
Profile of Pfizer Pharmaceuticals
Financial Analysis of Pfizer Incorporation
Table: 2005, 2006 and 2007 Accounting Ratios
Liquidity of Pfizer Incorporation
Asset Utilization of Pfizer Incorporation
Profitability of Pfizer Incorporation
Stability and Debt Management of Pfizer Incorporation
Investors Ratios
Computation of Accounting Ratios
Liquidity Ratios
Cash Conversional Cycle
Profitability Ratios
Stability and Debt Management
Investors Ratios
Final Thought - Shareholder Value

From the Paper
"Another important element of the financial position of the company is the cash flow of the company. Indeed the Cash Conversional Cycle was computed in section 1.2 of this paper to outline such area. The ratios express the length of time, in days, which a firm takes to convert the resource inputs into cash flow. A steady decrease in this matrix is noted over the three years examined from 271 days to 183 days. This is a positive element for the liquidity of the organization because management is more effective in translating the revenue transactions into cash."

Tags:risk, investors, profitability, equity, liquidity

Abstract
This paper takes a look at how the pharmaceutical company Pfizer has been quite effective at utilizing marketing strategy based market development to expand its revenue streams and extend the useful life of its existing products. The paper maintains that Pfizer's sales and marketing division is one of the drug industries best and has been a strong contributor to creating one of the most pathological advertising establishments in the United States. The paper uses the Ansoff matrix as a tool to assess Pfizer's marketing strategies in relation to the general drug market. The paper concludes that Pfizer owes its success to its vast resources, global distribution and channel technology, and brand equity.

Outline:
Introduction
Gap Analysis
Ansoff's Matrix-Strategic Planning
Recommended Solutions
Conclusion

From the Paper
"There are several strategies to accomplish growth. One of the easiest from an operational standpoint is to simply acquire or merge with another company which is inline with Ansoff's market or product development strategy. The exact nature of the strategy is dependent upon the character of the businesses being acquired or merged with. Mergers and acquisitions (M&A) provide companies with an instant expanded market and a new product or product line as well as, potentially, a completely new industry. If the M&A target is a company that focuses on a different market or market segment this would be a strategy based on market development because the primary company would be moving into what is, in effect, according to Ansoff, a new market."

Tags:drug, product, chemistry, pill, Ansoff, matrix, medicine

Abstract
This paper explains that Pfizer has built a strong business around product development and product marketing that leaves its competitors at a disadvantage in their efforts to mimic its operations. The author points out that the Ansoff Matrix is an excellent tool to weigh various potential marketing strategies. The paper relates that ideally marketing strategies should be linked to overall corporate strategy and organizational objectives as outlined by the enterprise's executive leadership. The author indicates that another growth option is to expand organically from within Pfizer. The paper concludes that, because of Pfizer's success with Lipitor, which Pfizer markets worldwide, the company should continue to capitalize on this product by creating a generic Lipitor line extension. The author continues with an analysis of this marketing strategy.

Table of Contents:
Overview
Strategy Development
Ansoff's Growth Matrix
Synthesis of Objectives
Growth Strategies
Option One
Option Two
Target Market
Positioning
Product
Placement (Distribution)
Pricing
Promotion
Conclusion

From the Paper
"As soon as Pfizer is forced to go to market with its own generic version of Lipitor at reduced prices, the first year sales objective is to level Lipitor sales at $5-7 billion globally and to reach generic Lipitor sales of $3 to 5 billion. In so doing, the majority of Lipitor's research and development expenses will maintain substantial revenues. Current prices for Lipitor average $77 for a 30 day supply (Pfizer, 2005). The target price for the generic version should be $45 for a comparable supply."

Tags:objectives, product development, lipitor generic online

Abstract
This paper examines how Pfizer is one of the most successful pharmaceutical companies in existence and how much, if not most, of Pfizer's success is due to the corporation's marketing genius, which is considered to be among the best in the industry. It looks at how Pfizer also has one of the best safety records in the industry, which helps in gaining investors and trust in the company. It also explores how, unlike most large corporations, Pfizer draws revenue from a limited number of products.

Outline
Company Structure and Marketing Strategies
Marketing Strengths
Threats

From the Paper
"The marketing principles utilized by Pfizer guides every aspect of the corporation's business. There are five main principles that are fundamental to Pfizer's business practices. First, the work conducted by Pfizer is grounded in science. With solid clinical research as a foundation, Pfizer's marketing group uses its credibility and knowledge to develop important relationships within the medical community. Second, Pfizer takes an integrated approach to its marketing strategies. Innovation is promoted through the encouragement of teamwork within and across marketing groups. This also allows Pfizer to respond flexibly and promptly to changes in the market."

Tags:viagra, profit, market, research, drugs